Sign In
to Vote &
Create Storyboards.
 
US drug firm Merck says existing Trump tariffs will cost it $200m this year Company's forecast does not account for threatened 'major' tariff that could also be levied on pharmaceutical imports Business live - latest updates The US pharmaceutical company Merck has said it expects to pay an extra $200m (£150m) in costs this year from tariffs that Donald Trump has already imposed, including his 10% tax on imports from around the world. Merck said the projected costs also included retaliatory tariffs imposed by foreign governments on the US, particularly those related to ...
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard